MELISSA FOWLER: Open Payments
NPI 1629334271 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 114 payments from 16 companies in 2025. Trend: 2023 $1,674 · 2024 $3,188 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $534 |
| ABBVIE INC. | 22 | $430 |
| Amgen Inc. | 24 | $392 |
| AstraZeneca Pharmaceuticals LP | 10 | $180 |
| Janssen Biotech, Inc. | 5 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $148 |
| Organon LLC | 8 | $129 |
| GENZYME CORPORATION | 4 | $115 |
| Radius Health, Inc. | 5 | $107 |
| PFIZER INC. | 4 | $101 |
Products named: Bimzelx, RINVOQ, TREMFYA, SKYRIZI, SAPHNELO, KEVZARA, Tymlos, KRYSTEXXA.
Industry payments across AZ — which companies pay providers there.
